Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jan 1;5(1):e8521.
doi: 10.1371/journal.pone.0008521.

Human prion diseases in the United States

Affiliations

Human prion diseases in the United States

Robert C Holman et al. PLoS One. .

Abstract

Background: Prion diseases are a family of rare, progressive, neurodegenerative disorders that affect humans and animals. The most common form of human prion disease, Creutzfeldt-Jakob disease (CJD), occurs worldwide. Variant CJD (vCJD), a recently emerged human prion disease, is a zoonotic foodborne disorder that occurs almost exclusively in countries with outbreaks of bovine spongiform encephalopathy. This study describes the occurrence and epidemiology of CJD and vCJD in the United States.

Methodology/principal findings: Analysis of CJD and vCJD deaths using death certificates of US residents for 1979-2006, and those identified through other surveillance mechanisms during 1996-2008. Since CJD is invariably fatal and illness duration is usually less than one year, the CJD incidence is estimated as the death rate. During 1979 through 2006, an estimated 6,917 deaths with CJD as a cause of death were reported in the United States, an annual average of approximately 247 deaths (range 172-304 deaths). The average annual age-adjusted incidence for CJD was 0.97 per 1,000,000 persons. Most (61.8%) of the CJD deaths occurred among persons >or=65 years of age for an average annual incidence of 4.8 per 1,000,000 persons in this population. Most deaths were among whites (94.6%); the age-adjusted incidence for whites was 2.7 times higher than that for blacks (1.04 and 0.40, respectively). Three patients who died since 2004 were reported with vCJD; epidemiologic evidence indicated that their infection was acquired outside of the United States.

Conclusion/significance: Surveillance continues to show an annual CJD incidence rate of about 1 case per 1,000,000 persons and marked differences in CJD rates by age and race in the United States. Ongoing surveillance remains important for monitoring the stability of the CJD incidence rates, and detecting occurrences of vCJD and possibly other novel prion diseases in the United States.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Creutzfeldt-Jakob disease deaths and age-adjusted death rates, United States, 1979–2006.
Figure 2
Figure 2. Creutzfeldt-Jakob disease age-specific and age-adjusted death rates, United States, 1979–2006.
Figure 3
Figure 3. Creutzfeldt-Jakob disease deaths and death rates by age group, United States, 1979–2006.

Similar articles

Cited by

References

    1. Belay ED. Transmissible spongiform encephalopathies in humans. Annu Rev Microbiol. 1999; 53:283–314. - PubMed
    1. Belay ED, Schonberger LB. The public health impact of prion diseases. Annu Rev Public Health. 2005; 26:191–212. - PubMed
    1. Moore RA, Taubner LM, Priola SA. Prion protein misfolding and disease. Curr Opin Struct Biol. Jan 19 2009 - PMC - PubMed
    1. Belay ED, Schonberger LB. Variant Creutzfeldt-Jakob disease and bovine spongiform encephalopathy. Clin Lab Med. Dec 2002. 22(4):849–862, v–vi. - PubMed
    1. Hsiao K, Meiner Z, Kahana E, Cass C, Kahana I, et al. Mutation of the prion protein in Libyan Jews with Creutzfeldt-Jakob disease. N Engl J Med. Apr 18 1991. 324(16):1091–1097. - PubMed